132 related articles for article (PubMed ID: 2113517)
1. MM 45289, a potent glycopeptide antibiotic which interacts weakly with diacetyl-L-lysyl-D-alanyl-D-alanine.
Good VM; Gwynn MN; Knowles DJ
J Antibiot (Tokyo); 1990 May; 43(5):550-5. PubMed ID: 2113517
[TBL] [Abstract][Full Text] [Related]
2. Molecular interactions between glycopeptide vancomycin and bacterial cell wall peptide analogues.
Xing B; Jiang T; Wu X; Liew R; Zhou J; Zhang D; Yeow EK
Chemistry; 2011 Dec; 17(50):14170-7. PubMed ID: 22083883
[TBL] [Abstract][Full Text] [Related]
3. A fluorescent ligand for binding studies with glycopeptide antibiotics of the vancomycin class.
Popieniek PH; Pratt RF
Anal Biochem; 1987 Aug; 165(1):108-13. PubMed ID: 3688425
[TBL] [Abstract][Full Text] [Related]
4. Molecular modeling of Gram-positive bacteria peptidoglycan layer, selected glycopeptide antibiotics and vancomycin derivatives modified with sugar moieties.
Ślusarz R; Szulc M; Madaj J
Carbohydr Res; 2014 May; 389():154-64. PubMed ID: 24685455
[TBL] [Abstract][Full Text] [Related]
5. N'-(alpha-aminoacyl)- and N'-alpha-(N-alkylamino)acyl derivatives of vancomycin and eremomycin. II. Antibacterial activity of N'-(alpha-aminoacyl)- and N'-alpha-(N-alkylamino)acyl derivatives of vancomycin and eremomycin.
Plattner JJ; Chu D; Mirchink EP; Isakova EB; Preobrazhenskaya MN; Olsufyeva EN; Miroshnikova OV; Printsevskaya SS
J Antibiot (Tokyo); 2007 Apr; 60(4):245-50. PubMed ID: 17456974
[TBL] [Abstract][Full Text] [Related]
6. Glycopeptide antibiotics: a mechanism-based screen employing a bacterial cell wall receptor mimetic.
Rake JB; Gerber R; Mehta RJ; Newman DJ; Oh YK; Phelen C; Shearer MC; Sitrin RD; Nisbet LJ
J Antibiot (Tokyo); 1986 Jan; 39(1):58-67. PubMed ID: 3949630
[TBL] [Abstract][Full Text] [Related]
7. D-Alanyl-D-lactate and D-alanyl-D-alanine synthesis by D-alanyl-D-alanine ligase from vancomycin-resistant Leuconostoc mesenteroides. Effects of a phenylalanine 261 to tyrosine mutation.
Park IS; Walsh CT
J Biol Chem; 1997 Apr; 272(14):9210-4. PubMed ID: 9083053
[TBL] [Abstract][Full Text] [Related]
8. Differential inhibition of Staphylococcus aureus PBP2 by glycopeptide antibiotics.
Leimkuhler C; Chen L; Barrett D; Panzone G; Sun B; Falcone B; Oberthür M; Donadio S; Walker S; Kahne D
J Am Chem Soc; 2005 Mar; 127(10):3250-1. PubMed ID: 15755121
[TBL] [Abstract][Full Text] [Related]
9. [The structure and antimicrobial activity of the partial degradation products of the antibiotic eremomycin].
Berdnikova TF; Lomakina NN; Olsuf'eva EN; Aleksandrova LG; Potapova NP; Rozynov BV; Malkova IV; Orlova GI
Antibiot Khimioter; 1991 Jun; 36(6):28-31. PubMed ID: 1910324
[TBL] [Abstract][Full Text] [Related]
10. First principles investigation of vancomycin and teicoplanin binding to bacterial cell wall termini.
Lee JG; Sagui C; Roland C
J Am Chem Soc; 2004 Jul; 126(27):8384-5. PubMed ID: 15237988
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and mode of action of hydrophobic derivatives of the glycopeptide antibiotic eremomycin and des-(N-methyl-D-leucyl)eremomycin against glycopeptide-sensitive and -resistant bacteria.
Printsevskaya SS; Pavlov AY; Olsufyeva EN; Mirchink EP; Isakova EB; Reznikova MI; Goldman RC; Branstrom AA; Baizman ER; Longley CB; Sztaricskai F; Batta G; Preobrazhenskaya MN
J Med Chem; 2002 Mar; 45(6):1340-7. PubMed ID: 11882003
[TBL] [Abstract][Full Text] [Related]
12. Balhimycin, a new glycopeptide antibiotic produced by Amycolatopsis sp. Y-86,21022. Taxonomy, production, isolation and biological activity.
Nadkarni SR; Patel MV; Chatterjee S; Vijayakumar EK; Desikan KR; Blumbach J; Ganguli BN; Limbert M
J Antibiot (Tokyo); 1994 Mar; 47(3):334-41. PubMed ID: 8175486
[TBL] [Abstract][Full Text] [Related]
13. A rational strategy for enhancing the affinity of vancomycin towards depsipeptide ligands.
Axelsen PH; Li D
Bioorg Med Chem; 1998 Jul; 6(7):877-81. PubMed ID: 9730223
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological activity of derivatives of glycopeptide antibiotics eremomycin and vancomycin nitrosated, acylated or carbamoylated at the N-terminal.
Pavlov AY; Berdnikova TF; Olsufyeva EN; Lazhko EI; Malkova IV; Preobrazhenskaya MN; Testa RT; Petersen PJ
J Antibiot (Tokyo); 1993 Nov; 46(11):1731-9. PubMed ID: 8270496
[TBL] [Abstract][Full Text] [Related]
15. Partitioning the loss in vancomycin binding affinity for D-Ala-D-Lac into lost H-bond and repulsive lone pair contributions.
McComas CC; Crowley BM; Boger DL
J Am Chem Soc; 2003 Aug; 125(31):9314-5. PubMed ID: 12889959
[TBL] [Abstract][Full Text] [Related]
16. Molecular interactions of a semisynthetic glycopeptide antibiotic with D-alanyl-D-alanine and D-alanyl-D-lactate residues.
Allen NE; LeTourneau DL; Hobbs JN
Antimicrob Agents Chemother; 1997 Jan; 41(1):66-71. PubMed ID: 8980756
[TBL] [Abstract][Full Text] [Related]
17. Teicoplanin, a new antibiotic from Actinoplanes teichomyceticus nov. sp.
Somma S; Gastaldo L; Corti A
Antimicrob Agents Chemother; 1984 Dec; 26(6):917-23. PubMed ID: 6240963
[TBL] [Abstract][Full Text] [Related]
18. Calculation of concentrations of equilibrium components in an in vitro activity test of vancomycin antibiotics and the possible mode of action.
Yan H; Cheng X; He B
Biophys Chem; 1998 Aug; 74(2):107-15. PubMed ID: 9760722
[TBL] [Abstract][Full Text] [Related]
19. The role of hydrophobic side chains as determinants of antibacterial activity of semisynthetic glycopeptide antibiotics.
Allen NE; LeTourneau DL; Hobbs JN
J Antibiot (Tokyo); 1997 Aug; 50(8):677-84. PubMed ID: 9315081
[TBL] [Abstract][Full Text] [Related]
20. [The structure of antibiotic eremomycin B].
Berdnikova TF; Shashkov AS; Katrukha GS; Lapchinskaia OA; Iurkevich NV; Grachev AA; Nifant'ev NE
Bioorg Khim; 2009; 35(4):550-6. PubMed ID: 19928058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
